Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
GSK2830930A
- Development stage
- Phase 2
- Lead developer
- GSK
- Modality
- Vaccines & Immunotherapeutics
- Administration
- Intramuscular
01
Overview
GSK2830930A is an investigational formulation of GlaxoSmithKline's pneumococcal conjugate vaccine (PCV). It is a 10-valent vaccine (PHiD-CV) designed to provide active immunization against invasive disease, pneumonia, and acute otitis media caused by *Streptococcus pneumoniae* serotypes 1, 4, 5, 6B, 7F, 9V, 14, 18C, 19F, and 23F. The vaccine utilizes the non-typeable *Haemophilus influenzae* (NTHi) protein D as a carrier protein for eight of the serotypes, while tetanus toxoid and diphtheria toxoid are used for the remaining two. GSK2830930A was evaluated in Phase 2 clinical trials to assess its safety, reactogenicity, and immunogenicity in infants and toddlers, often in comparison with other candidate formulations and co-administered with routine pediatric vaccines like Infanrix hexa.
- Other names
- GSK pneumococcal vaccine10-valent pneumococcal conjugate vaccinePHiD-CV formulation
02
Targets
CPS (Streptococcus pneumoniae capsular polysaccharide)
Beyond the preview
Go deeper on GSK2830930A.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on GSK2830930A.